TRAVERE THERAPEUTICS, INC. Exchange Rate Effect on Cash
TRAVERE THERAPEUTICS, INC. (TVTX) reported Exchange Rate Effect on Cash of -$135.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2019-02-26.
Discontinued › Cash Flow › Change in Cash
us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents · last filed 2019-02-26
- TRAVERE THERAPEUTICS, INC. effect of exchange rate on cash and cash equivalents for the quarter ending 2018-03-31 was $10.00K, a 150.00% increase year-over-year.
- TRAVERE THERAPEUTICS, INC. effect of exchange rate on cash and cash equivalents for the quarter ending 2017-03-31 was $4.00K.
- TRAVERE THERAPEUTICS, INC. effect of exchange rate on cash and cash equivalents for the quarter ending 2016-03-31 was -$294.00K.
- TRAVERE THERAPEUTICS, INC. effect of exchange rate on cash and cash equivalents for the quarter ending 2015-03-31 was $0.00.
- TRAVERE THERAPEUTICS, INC. effect of exchange rate on cash and cash equivalents for fiscal 2018 was -$135.00K.
- TRAVERE THERAPEUTICS, INC. effect of exchange rate on cash and cash equivalents for fiscal 2017 was -$58.00K, a 149.57% decline from fiscal 2016.
- TRAVERE THERAPEUTICS, INC. effect of exchange rate on cash and cash equivalents for fiscal 2016 was $117.00K.
- TRAVERE THERAPEUTICS, INC. effect of exchange rate on cash and cash equivalents for fiscal 2015 was -$10.00K.
| Period end | Effect of Exchange Rate on Cash and Cash Equivalents 3 month | Effect of Exchange Rate on Cash and Cash Equivalents 3 month as first filed | Effect of Exchange Rate on Cash and Cash Equivalents 6 month | Effect of Exchange Rate on Cash and Cash Equivalents 6 month as first filed | Effect of Exchange Rate on Cash and Cash Equivalents 9 month | Effect of Exchange Rate on Cash and Cash Equivalents 12 month |
|---|---|---|---|---|---|---|
| 2018-12-31 | -$135.00K 10-K · filed 2019-02-26 | |||||
| 2018-09-30 | -$30.00K 10-Q · filed 2018-11-01 | |||||
| 2018-06-30 | -$34.00K 10-Q · filed 2018-08-03 | |||||
| 2018-03-31 | $10.00K 10-Q · filed 2018-07-06 | |||||
| 2017-12-31 | -$58.00K 10-K · filed 2019-02-26 | |||||
| 2017-09-30 | -$57.00K 10-Q · filed 2018-11-01 | |||||
| 2017-06-30 | $63.00K 10-Q · filed 2018-08-03 | -$497.00K 10-Q · filed 2017-08-09 | ||||
| 2017-03-31 | $4.00K 10-Q · filed 2018-07-06 | -$119.00K 10-Q · filed 2017-05-05 | ||||
| 2016-12-31 | $117.00K 10-K · filed 2019-02-26 | |||||
| 2016-09-30 | -$57.00K 10-Q · filed 2017-11-07 | |||||
| 2016-06-30 | -$182.00K 10-Q · filed 2017-08-09 | |||||
| 2016-03-31 | -$294.00K 10-Q · filed 2017-05-05 | |||||
| 2015-12-31 | -$10.00K 10-K · filed 2018-07-06 | |||||
| 2015-09-30 | $0.00 10-Q · filed 2016-11-04 | |||||
| 2015-06-30 | $0.00 10-Q · filed 2016-08-05 | |||||
| 2015-03-31 | $0.00 10-Q · filed 2016-05-05 | |||||
| 2014-12-31 | $0.00 10-K · filed 2017-03-01 | |||||
| 2013-12-31 | $0.00 10-K · filed 2016-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B |